Table 2.

Clinical characteristics and plasma carbamylated lipoproteins in individuals with diabetes with eGFR >60 ml/min per 1.73 m2 and the nondiabetic control group

Age, yr48±748±6
Men/women, %50/5049/51
BMI, kg/m225±326±4
Smoker, %1412
Duration of diabetes, yr9 (6–14)
Lipid-lowering therapy, %0
Fasting glucose, mg/dl87±9158±55
HbA1c, %5.6±0.58.5±1.6
eGFR, ml/min per 1.73 m281±1283±16
Total cholesterol, mg/dl189±26189±31
Triglyceride, mg/dl89 (62–124)115 (80–177)
LDL cholesterol, mg/dl112±24113±28
HDL cholesterol, mg/dl55±1448±12
Carbamylated LDL, µg/ml267 (171–388)340 (214–548)
Carbamylated HDL, µg/ml26±1031±12
  • Data are expressed as mean±SD or median (interquartile range). BMI, body mass index; —, not applicable; HbA1c, hemoglobin A1c.